Bye bye Sumitomo

Discussion in 'Sunovion' started by Bye bye Sumitomo, Aug 1, 2023 at 5:15 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    What answers do you want? I can help.
     

  2. anonymous

    anonymous Guest

    There are many people, across business units and levels, that feel exactly the same way.
    Can't wait for the next survey.
     
  3. anonymous

    anonymous Guest

    That’s comical if you believe company gives 2 shits about surveys at this point.
     
  4. anonymous

    anonymous Guest

    Let’s be honest all the leadership team is doing now is trying to implement useless BS to the field in a desperate attempt to add phony job skills onto their resumes in attempt land their next jobs.
     
  5. anonymous

    anonymous Guest

     
  6. anonymous

    anonymous Guest

    What do I want to know…hmmm, are they going to honor those in women’s health for Chairman’s? Or just ignore anyone’s success. What’s going on with upper management and why everyone is leaving? What is their vision for remainder of 2024?
     
  7. anonymous

    anonymous Guest

    I should have stayed at Astellas.
     
  8. anonymous

    anonymous Guest

    Sounds like a personal problem. Dumbo
     
  9. anonymous

    anonymous Guest

    This ‘targeting’ and call system is a JOKE. Where they got the data for the mspec team and wh is beyond me. Adele and Melissa, you overpaid someone for the data. It is beyond horrible as far as targeting. You CANNOT grow the business with the targets you have and the preferential treatment to Pfizer who, btw, doesn’t record things accurately! When you tie ppls bonuses (Pfizer) to having a certain amount of calls on said targets, guess what??? You are going to ‘get’ calls on those targets whether you can see them or not!
    Why oh why would you not actually defer to someone (not Pfizer) with some real experience with this specialty?
    You are proving you are setting us up to FAIL. Shame on you!
     
  10. anonymous

    anonymous Guest

    Put yourself out of misery pal. Mspec will follow the patterns of the other divisions and be gone in a year.
     
  11. anonymous

    anonymous Guest

    Yes, stupid decisions..no foresight for success, let’s do this and see if it works?! Nope, we will just lay more good ppl off and try again. The blind leading the blind
     
  12. anonymous

    anonymous Guest

    Those of us out west have thrown the towel in months ago. You cant fight dumbness. Many of the better reps out west have already departed. There is nothing left here that’s not on a firehouse sale track and that includes mspec.
     
  13. anonymous

    anonymous Guest

    The GOOD news (which is rare these days) is the NSM has been cancelled!
     
  14. anonymous

    anonymous Guest

    how did Adele and Melissa become the decision makers for a specialty medication they have no experience with. Relying on Pfizer who has had nothing new in the OB decades. Myfembree is not a primary care product and they are dumbing everything down.
     
  15. anonymous

    anonymous Guest

    Agreed. And they want us to be showing big results by July, it will take a month minimum to figure out the new territories. Such unrealistic expectations
     
  16. anonymous

    anonymous Guest

    Look let’s be honest, this place is a paycheck for the next 12-18 months maybe and nothing more. If you think you can stick it out fine but expect much more incompetence from leadership along the way.
     
  17. anonymous

    anonymous Guest

    My manager still wants us to do our career growth plans for our jobs here.
     
  18. anonymous

    anonymous Guest

    Lug heads are best description for these mindless leaders. They can’t figure out how to get their own heads out of the ground.
     
  19. anonymous

    anonymous Guest

    12-18 months is very generous, what are you basing that on? In my opinion I would guess as little as 6 months to as much as 10 months at best.
     
  20. anonymous

    anonymous Guest

    Look at previous history. They bleed each brand down to the last drop before cutting that given sales force. Gemtesa is next on the list within next 12-18 months. This company has proven that its awful leadership is incapable of developing or acquiring new products.